BA08: An open-label, single-arm, non-randomised, phase 2 trial of cisplatin, methotrexate and vinblastine (CMV) for pure squamous cell cancer of the urinary tract.
Gareth O GriffithsRichard A CowanKenneth M GrigorBarbara M UscinskaMatthew SydesJ Martin RussellPublished in: PloS one (2019)
CMV is well tolerated and active in patients with pure SCC of the urinary tract.